A few highlights from around the web that made it into our feeds this week.
Health Brief: Childhood Safety Vaccine Report Remains in Limbo
As measles cases in the US surpass 5,100, a long-awaited federal report on childhood vaccine safety remains in limbo, and the advisory committee meant to review it is caught in its own legal battle. This briefing examines the uncertainty surrounding federal vaccine policy, alongside CDC Director Erika Schwartz’s efforts to rebuild trust within the agency and reach communities skeptical of vaccination. The timing is particularly unsettling; we know how to prevent measles, yet the institutions and public confidence needed to sustain that progress are looking increasingly fragile. (From washingtonpost.com)
GLP-1s Are Rewriting the Story of Weight Loss and Mental Health
Weight-loss apps are offering meditation, cognitive behavioral tools, even guided moments with Monet. As GLP-1s reshape the industry, companies are increasingly embracing mental health as part of the weight-loss conversation. But is this a genuine shift toward treating the whole person, or simply a more appealing way to sell weight loss? This article explores that obvious conflict, examining the mixed evidence on how GLP-1s affect mood, the persistent stigma surrounding their use, and the psychological toll of weight loss itself. A thoughtful look at why emotional support is critical, even if the industry's motives deserve some scrutiny. (From theatlantic.com)
The Year Math Changed Forever
This is a long one, but well worth the time. Through mathematician Terence Tao and his colleagues, this piece explores a field undergoing an extraordinary upheaval as AI begins tackling problems that have stumped some of the world's greatest mathematical minds. The breakthroughs are remarkable, though not all the claims have been verified, and the implications reach far past mathematics. What happens to curiosity, discovery, and the very process of learning when answers arrive faster than we can understand them? A fascinating examination of the difference between solving a problem and understanding the ‘why’ behind the solution. (From newyorker.com)
Prostate Cancer Screening Now Broadly Recommended, Reversing Past Guidance
A significant shift in prostate cancer screening—The American Cancer Society now recommends routine PSA testing every two years for men ages 50 to 69, with earlier annual screening for Black men and those with a strong family history. New evidence of reduced mortality, along with advances in MRI and active surveillance, helped drive the change. Still, the longstanding concerns about overdiagnosis and overtreatment haven't disappeared. This is a useful examination of the evidence on both sides, and why even a test that saves lives can carry consequences for patients whose cancers might never have caused harm. (From nytimes.com)
Related:
- Dr AI: Can ChatGPT Step Up To the Medical Challenge?
- Your Heart Has a Brain of Its Own
- State of the Union: The Stealth Innovations of Modern Surgical Care